Journal
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Volume 41, Issue 4, Pages 744-747Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.biocel.2008.05.029
Keywords
24(S),25-Epoxycholesterol; Oxysterol; Statins; Lanosterol synthase
Categories
Funding
- National Health and Medical Research Council [350828]
- Prostate Cancer Foundation of Australia [PR36]
Ask authors/readers for more resources
The oxysterol 24(S),25-epoxycholesterol is made in a shunt in the cholesterol biosynthetic pathway in all cholesterogenic cells. Evidence is emerging that endogenous 24(S),25-epoxycholesterol can work at several levels to control acute cholesterol homeostasis. For instance, this oxysterol suppresses activation of the master regulators of cholesterol homeostasis, the sterol regulatory element binding proteins. Indeed, 24(S),25-epoxycholesterol appears to serve as a measure of cholesterol synthesis and to protect against surges in the production of this potentially cytotoxic molecule. In addition, endogenous 24(S),25-epoxycholesterol is a natural ligand for the liver X receptors which induce expression of cholesterol efflux-related genes. Levels of endogenous 24(S),25-epoxycholesterol can be artificially elevated by partially inhibiting the step after the start of the shunt, catalysed by oxidosqualene cyclase. The idea of manipulating a self-governing pathway for the production of a physiological regulator, that can enhance cholesterol removal and decrease uptake and synthesis, is attractive and warrants further evaluation. (C) 2008 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available